IL18 and acute kidney injury: According to a current systematic analysis of 11 studies in 2,796 patients, IL-18 is considered a promising biomarker with some diagnostic accuracy in the initial diagnosis of AKI, the AUC was 0.77 (95%CI 0.71–0.83) (Lin et al., 2015).